Low-dose PPIs (omeprazole 10 mg, esomeprazole 20 mg) are available over the counter for short-term use, but patients should consult their pharmacist or GP before prolonged use
Common Side Effects: GI discomfort Nausea, vomiting, constipation, diarrhea Skin reactions at injection site Rare Side Effects Needing Immediate Attention: Vision changes (seek emergency care for sudden vision loss) Permanent gastroparesis (chronic constipation or obstruction) Increased risk of thyroid cancer (check neck for nodules) Not recommended for individuals with personal or family history of: Medullary Thyroid Cancer Multiple Endocrine Neoplasia (MEN) Injectable medication outcomes: 1
Urschel JD, Vasan H, Blewett CJ
Currently, a phase 3 clinical trial program for retatrutide (TRIUMPH) is underway to assess its safety and efficacy in different obese patient populations, including those with obstructive sleep apnea (OSA), T2D, diagnosed cardiovascular disease, osteoarthritis, and others
That sounds convenient, but for microdosing, it creates a precision problem